MicroRNA 21 (MiR21)-enriched EVs activate the VEGF pathway and increase endothelial cell proliferation [42], whereas miR-1-rich EVs reduce the pro-angiogenic impact and thereby limit GBM-associated angiogenesis [31]. The gene discussed is VEGFA; the disease is glioblastoma.